HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Noxzema Skin Fitness K-3 Triple-Blade Razor Bowing Under Licensing Deal

This article was originally published in The Rose Sheet

Executive Summary

Procter & Gamble is expanding its Noxzema Skin Fitness skin care line into women's shave system and disposable razors under a licensing deal with private label company Universal Group (Los Angeles).
Advertisement

Related Content

Noxzema Shave Gels Debut To Target Women
Noxzema Shave Gels Debut To Target Women
P&G Shaving Products Licensing Agreement To Enhance Noxzema, Old Spice
P&G Shaving Products Licensing Agreement To Enhance Noxzema, Old Spice
Gillette Mach3 Sister System Backed By $40 Mil. Marketing Spend
Gillette Mach3 Sister System Backed By $40 Mil. Marketing Spend
American SafetyTri-Flexxx Triple-Blade Infringes Mach3 Patents - Suit
Noxzema Skin Fitness Collection Exercises Innovative Web-Driven Promotions
Noxzema Skin Fitness Collection Exercises Innovative Web-Driven Promotions
Gillette Mach3 shave system represents $750 mil. R&D, manufacturing capital investment.
Advertisement
UsernamePublicRestriction

Register

RS007400

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel